Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Schreiber, Peter W; Schmid, Adrian; Fagagnini, Stefania; Kröger, Arne; Vrugt, Bart; Reiner, Cäcilia S; Boggian, Katia; Schiesser, Marc; Müllhaupt, Beat; Günthard, Huldrych F (2018). MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma. Open Forum Infectious Diseases, 5(4):ofy052.

Madanchi, Matiar; Fagagnini, Stefania; Fournier, Nicolas; Biedermann, Luc; Zeitz, Jonas; Battegay, Edouard; Zimmerli, Lukas; Vavricka, Stephan R; Rogler, Gerhard; Scharl, Michael; et al; Swiss IBD Cohort Study Group (2018). The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort. Inflammatory Bowel Diseases, 24(8):1768-1779.

Fagagnini, Stefania; Heinrich, Henriette; Rossel, Jean-Benoît; Biedermann, Luc; Frei, Pascal; Zeitz, Jonas; Spalinger, Marianne; Battegay, Edouard; Zimmerli, Lukas; Vavricka, Stephan R; Rogler, Gerhard; Scharl, Michael; Misselwitz, Benjamin (2017). Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases. PLoS ONE, 12(10):e0185193.

Goffin, Laurence; Fagagnini, Stefania; Vicari, Alain; Mamie, Céline; Melhem, Hassan; Weder, Bruce; Lutz, Christian; Lang, Silvia; Scharl, Michael; Rogler, Gerhard; Chvatchko, Yolande; Hausmann, Martin (2016). Anti-MMP-9 Antibody: A promising therapeutic strategy for treatment of inflammatory bowel disease complications with fibrosis. Inflammatory Bowel Diseases, 22(9):2041-2057.

Meier, Remo; Lutz, Christian; Cosín-Roger, Jesus; Fagagnini, Stefania; Bollmann, Gabi; Hünerwadel, Anouk; Mamie, Celine; Lang, Silvia; Tchouboukov, Alexander; Weber, Franz E; Weber, Achim; Rogler, Gerhard; Hausmann, Martin (2016). Decreased fibrogenesis after treatment with pirfenidone in a newly developed mouse model of intestinal fibrosis. Inflammatory Bowel Diseases, 22(3):569-582.

This list was generated on Thu Nov 15 21:49:49 2018 CET.